SEARCH RESULTS FOR: "Tag: PFE"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2022(6)
2021(40)
2020(58)
2019(14)
2018(19)
2017(23)
2016(40)
2015(22)
2014(4)
CATEGORIES
5-Minute Market Rundown(13)
Analyst Downgrades(3)
Analyst Update(7)
Analyst Upgrades(2)
Bernie's Content(1)
Buzz Stocks(42)
Earnings Preview(6)
Editor's Pick(1)
Expectational Analysis(1)
Ezines(10)
General(4)
Indicator of the Week(1)
Intraday Option Activity(19)
Market Recap(29)
Midday Market Check(27)
Opening View(60)
Quantitative Analysis(1)
Stock Market News(5)
Stocks On the Move(12)
Strategies and Concepts(1)
The Week Ahead(14)
Trader Content(1)
Unusual Trading Activity(1)

7/18/2022 1:15 AM
There are short-term and long-term opportunities for PFE stock Pfizer ( NYSE: PFE ) stock is down 12% in 2022. Even though that’s better than the broader market, there are some concerns that Pfiz...
4/28/2022 4:11 PM
Pfizer Inc. (NYSE:PFE) is on the spotlight, after announcing the European Commission granted marketing authorization for VYDURA, the first medicine approved for both acute and prophylactic treatment o...
4/28/2022 2:41 PM
People will always need medical treatment regardless of what is going on with the economy, which makes stocks in the healthcare sector consistently reliable investments. The Covid-19 pandemic put a...
4/20/2022 5:53 PM
In honor of today being April 20, aka "weed day" and the unofficial cannabis holiday, we figured it was worth covering the cannabis stocks that have come and already gone despite the overall thriving ...
3/16/2022 11:00 AM
Pfizer Inc (NYSE:PFE) and partner BioNTech SE (NASDAQ:BNTX) filed an application with the U.S. Food and Drug Administration this morning to approve emergency use authorization for a second booster s...